Artel

Nova Biomedical is entering a new chapter. Advanced Instruments and Nova Biomedical have united to form a larger, more focused global life science tools company operating under the Nova Biomedical name. By bringing together two innovation‑driven organizations, we have expanded our capabilities across bioprocessing and clinical diagnostics, strengthening how we serve customers and accelerating our impact across life sciences. Today’s Nova Biomedical is a global leader in supporting bioprocessing workflows and in vitro diagnostics (IVD), guided by a renewed leadership team, sharper priorities, and a clear focus on innovation, quality, and customer outcomes. We are committed to advancing patient care and scientific discovery through reliable, high‑performance technologies backed by disciplined execution and long‑term investment. Our portfolio includes: Clinical Diagnostics: Blood gas, critical care, and glucose analyzers that deliver fast, accurate results to support confident clinical decisions. Bioprocessing Solutions: Cell line development solutions, real‑time cell culture monitoring and process optimization, helping customers improve productivity, quality, and scale. Veterinary Diagnostics: High‑performance diagnostic solutions designed for animal health applications. We reinvest annually into research and development, fueling a strong pipeline of breakthrough technologies and reinforcing our leadership in innovation. As the largest privately held IVD company in the U.S. and one of the fastest‑growing globally, Nova Biomedical serves customers in more than 100 countries. Our culture is grounded in integrity, accountability, and long‑term commitment, values reflected in the trust of our customers and the dedication of our people. As a new Nova Biomedical, we are focused on delivering consistent quality, meaningful innovation, and lasting impact—today and for what’s next. Learn more: www.novabiomedical.com